Omission of Radiation Therapy is Associated with Inferior Disease Control in High Risk Early-Stage Hodgkin Lymphoma
Adding radiation to chemotherapy improved disease control for bulky lymphomas, though survival remained similar and late side effects increased.
This retrospective multicenter propensity-matched cohort study examined Omission of Radiation Therapy is Associated with Inferior Disease Control in High Risk Early-Stage Hodgkin Lymphoma. Radiotherapy omission was associated with inferior disease control in bulky or interim-PET-positive disease, while overall survival was similar and late toxicity was more frequent with combined therapy.
What the study was
- Study design
- Retrospective multicenter propensity-matched cohort study
- Population
- Adults with stage I or II classical Hodgkin lymphoma
- Sample size
- 810 patients; 480 propensity matched
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- Blood advances
Why it surfaced
Retrospective multicenter propensity-matched cohort study; Radiotherapy omission was associated with inferior disease control in bulky or interim-PET-positive disease, while overall survival was similar and late toxicity was more frequent with combined therapy. Score kept conservative because only the PubMed abstract and metadata were reviewed.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.